Home/Filings/4/0000899243-21-042213
4//SEC Filing

Larson Yi 4

Accession 0000899243-21-042213

CIK 0001831283other

Filed

Oct 31, 8:00 PM ET

Accepted

Nov 1, 7:20 PM ET

Size

5.6 KB

Accession

0000899243-21-042213

Insider Transaction Report

Form 4
Period: 2021-10-31
Larson Yi
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-10-31+229,5381,196,845 total
    Exercise: $16.00Exp: 2031-10-31Ordinary Shares (229,538 underlying)
Footnotes (1)
  • [F1]25% of the shares underlying the option shall vest and become exercisable on October 31, 2022; the remainder shall vest and become exercisable in three equal annual installments such that the option shall be fully vested on October 31, 2025, subject to the Reporting Person providing continuous service to the Issuer on each such date.

Issuer

LianBio

CIK 0001831283

Entity typeother

Related Parties

1
  • filerCIK 0001785987

Filing Metadata

Form type
4
Filed
Oct 31, 8:00 PM ET
Accepted
Nov 1, 7:20 PM ET
Size
5.6 KB